(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
It has been brought to the Company's attention that the government, both at the state and federal level, in Australia, through the
National E-Health Transition Authority (NEHTA), could possibly be infringing on patents belonging to the Company (including Australian patent numbers
2006202057 and 2008202401) and other Intellectual Property (collectively the "MMR IP") issued to
MyMedicalRecords.com, Inc., a wholly owned subsidiary of MMRGlobal, Inc. NEHTA has reportedly spent an estimated one billion
Australian dollars on a Personal Health Records Program which is the subject of the possible infringement, and which may
incorporate numerous portions of the MMR IP. The Company is planning on retaining counsel in Australia
to determine if any patent infringement of the MMR IP has occurred. At this time there can be no assurances as to the outcome of
any potential infringement by any Australian Government or NEHTA.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
February 5, 2013
By: /s/ Robert H. Lorsch
Robert H. Lorsch
Chief Executive Officer